MHIG Milliman Healthcare Inflation Guard ETF
Kuotasi per Aug 26, 2026 16:47 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Penutupan Sebelumnya | 20.59 | Rentang Harian | 20.40 – 20.49 |
| Kisaran 52 Minggu | 19.64 – 20.59 | Volume | 111 |
| Volume Rata-Rata | 122 | AUM | $988.5K (Aug 27, 2026) |
| Expense Ratio | 0.55% | Yield (TTM) | — |
| NAV | 20.22 | Premium/Diskon | +1.35% indikatif |
| Inception | Apr 21, 2026 | Kepemilikan | — |
| Penerbit | Milliman | Bursa | AMEX |
| Kategori | Healthcare | Indeks yang Dilacak | Tidak tercantum dalam data sumber |
| CUSIP | 600825103 | ISIN | US6008251034 |
| Manajemen | Tidak tercantum dalam data sumber | ||
Tentang ETF ini
MHIGaims to offset the rising medical costs, rather than general inflation,through proprietary actuarial data and quantitative modeling. The fundanalysis relies on Mis extensive dataset of real healthcare claims, covering approximately 35 million insured individuals, to project healthcare inflation based on trends in medical and pharmacy costs. Investments consist of equities and fixed income securities across the healthcare supply chain, along with inflation-hedging instruments such as commodities, TIPS, and Treasury bonds. Typically, MHIP is rebalanced monthly using a quantitative model to reflect changes in US healthcare cost inflation. The strategy increases exposure to equities and commodities during periods of higher inflation and shifts toward debt when inflation is lower. Holdings may also include derivatives such as swaps, options, and futures, as well as ETFs.
Deskripsi dari penyedia data dana · profil per Aug 27, 2026.
Grafik Harga
Harga penutupan harian (imbal hasil harga, bukan imbal hasil total). Garis perbandingan dinormalisasi ke perubahan persentase dari awal rentang waktu. Sumber: Financial Modeling Prep.
Kinerja
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Return harga | +3.59% | +2.71% | — | — | — | — | — | — | +1.74% |
| Total return | +3.59% | +2.71% | — | — | — | — | — | — | +1.74% |
* Disetahunkan. Total imbal hasil menggunakan seri harga yang disesuaikan dengan dividen (distribusi diinvestasikan kembali); imbal hasil harga menggunakan harga penutupan tanpa penyesuaian. Kinerja hingga Aug 26, 2026. Kinerja masa lalu tidak menjamin hasil di masa depan.
Biaya
| Expense ratio bersih | 0.55% | Biaya tahunan untuk investasi $10.000 | $55.00 |
Hanya kalkulasi ilustrasi: expense ratio × $10.000. Tidak termasuk biaya perdagangan, selisih bid/ask, pajak, dan perubahan nilai investasi. Detail expense ratio bruto vs. neto dan setiap pengabaian biaya tersedia dalam prospektus.
Kepemilikan
Kepemilikan per Aug 22, 2026 — tanggal pelaporan portofolio dari penyedia data; kepemilikan bukan posisi langsung. 86 baris dalam basis data.
| # | Kepemilikan | Ticker | Bobot | Saham | Nilai Pasar |
|---|---|---|---|---|---|
| 1 | BondBloxx Bloomberg Five Year Target Duration… | XFIV | 35.87% | 7.60K | $366.1K |
| 2 | United States Treasury Bill 11/19/2026 | — | 14.85% | 153.00K | $151.6K |
| 3 | BondBloxx Bloomberg Six Month Target Duration… | XHLF | 13.96% | 2.83K | $142.5K |
| 4 | State Street SPDR S&P 500 ETF Trust | SPY | 5.38% | 72 | $54.9K |
| 5 | Eli Lilly & Co | LLY | 5.12% | 42 | $52.3K |
| 6 | Johnson & Johnson | JNJ | 2.31% | 88 | $23.5K |
| 7 | AbbVie Inc | ABBV | 2.21% | 86 | $22.5K |
| 8 | 4GLD US 11/19/26 C372.46 FLX | — | 2.01% | 4 | $20.5K |
| 9 | Gilead Sciences Inc | GILD | 1.17% | 83 | $11.9K |
| 10 | Thermo Fisher Scientific Inc | TMO | 1.11% | 18 | $11.3K |
| 11 | Cash & Other | — | 1.06% | 10.78K | $10.8K |
| 12 | Amgen Inc | AMGN | 0.97% | 23 | $9.9K |
| 13 | Abbott Laboratories | ABT | 0.83% | 74 | $8.4K |
| 14 | UnitedHealth Group Inc | UNH | 0.75% | 20 | $7.7K |
| 15 | Danaher Corp | DHR | 0.72% | 34 | $7.3K |
| 16 | Intuitive Surgical Inc | ISRG | 0.62% | 17 | $6.4K |
| 17 | Stryker Corp | SYK | 0.61% | 19 | $6.2K |
| 18 | Pfizer Inc | PFE | 0.59% | 215 | $6.0K |
| 19 | Medtronic PLC | MDT | 0.58% | 64 | $5.9K |
| 20 | Bristol-Myers Squibb Co | BMY | 0.55% | 86 | $5.6K |
| 21 | CVS Health Corp | CVS | 0.52% | 57 | $5.3K |
| 22 | HCA Healthcare Inc | HCA | 0.44% | 11 | $4.5K |
| 23 | McKesson Corp | MCK | 0.41% | 5 | $4.2K |
| 24 | Merck & Co Inc | MRK | 0.38% | 26 | $3.9K |
| 25 | Boston Scientific Corp | BSX | 0.36% | 75 | $3.7K |
| 26 | ELEVANCE HEALTH INC | ELV | 0.35% | 9 | $3.6K |
| 27 | Cigna Group/The | CI | 0.32% | 12 | $3.3K |
| 28 | Centene Corp | CNC | 0.30% | 48 | $3.1K |
| 29 | Humana Inc | HUM | 0.26% | 7 | $2.7K |
| 30 | Natera Inc | NTRA | 0.25% | 8 | $2.6K |
| 31 | Edwards Lifesciences Corp | EW | 0.25% | 28 | $2.5K |
| 32 | Becton Dickinson & Co | BDX | 0.24% | 13 | $2.4K |
| 33 | Medline Inc | MDLN | 0.22% | 69 | $2.2K |
| 34 | Cencora Inc | COR | 0.22% | 7 | $2.2K |
| 35 | Dexcom Inc | DXCM | 0.20% | 23 | $2.1K |
| 36 | IQVIA Holdings Inc | IQV | 0.20% | 8 | $2.0K |
| 37 | Waters Corp | WAT | 0.20% | 5 | $2.0K |
| 38 | Veeva Systems Inc | VEEV | 0.20% | 8 | $2.0K |
| 39 | Agilent Technologies Inc | A | 0.18% | 12 | $1.9K |
| 40 | Cardinal Health Inc | CAH | 0.18% | 8 | $1.8K |
| 41 | ResMed Inc | RMD | 0.18% | 8 | $1.8K |
| 42 | Revolution Medicines Inc | RVMD | 0.17% | 8 | $1.7K |
| 43 | Labcorp Holdings Inc | LH | 0.16% | 5 | $1.7K |
| 44 | GE HealthCare Technologies Inc | GEHC | 0.15% | 21 | $1.6K |
| 45 | Quest Diagnostics Inc | DGX | 0.14% | 6 | $1.4K |
| 46 | Mettler-Toledo International Inc | MTD | 0.14% | 1 | $1.4K |
| 47 | Guardant Health Inc | GH | 0.13% | 8 | $1.3K |
| 48 | Illumina Inc | ILMN | 0.13% | 6 | $1.3K |
| 49 | STERIS PLC | STE | 0.12% | 5 | $1.2K |
| 50 | Alnylam Pharmaceuticals Inc | ALNY | 0.11% | 5 | $1.1K |
| 51 | Tenet Healthcare Corp | THC | 0.11% | 4 | $1.1K |
| 52 | West Pharmaceutical Services Inc | WST | 0.10% | 3 | $1.1K |
| 53 | Cooper Cos Inc/The | COO | 0.09% | 12 | $913.92 |
| 54 | ZIMMER BIOMET HOLDINGS INC | ZBH | 0.09% | 9 | $890.73 |
| 55 | Regeneron Pharmaceuticals Inc | REGN | 0.08% | 1 | $826.64 |
| 56 | Solventum Corp | SOLV | 0.08% | 9 | $797.49 |
| 57 | Molina Healthcare Inc | MOH | 0.08% | 4 | $787.76 |
| 58 | Revvity Inc | PKI | 0.07% | 6 | $744.78 |
| 59 | Globus Medical Inc | GMED | 0.07% | 8 | $685.36 |
| 60 | Penumbra Inc | PEN | 0.06% | 2 | $647.52 |
| 61 | Biogen Inc | BIIB | 0.06% | 3 | $643.05 |
| 62 | Align Technology Inc | ALGN | 0.06% | 4 | $635.76 |
| 63 | Baxter International Inc | BAX | 0.06% | 24 | $633.84 |
| 64 | Medpace Holdings Inc | MEDP | 0.06% | 1 | $612.64 |
| 65 | Neurocrine Biosciences Inc | NBIX | 0.06% | 4 | $611.72 |
| 66 | ENCOMPASS HEALTH CORP | EHC | 0.06% | 5 | $604.55 |
| 67 | Charles River Laboratories International Inc | CRL | 0.06% | 2 | $582.90 |
| 68 | Bio-Techne Corp | TECH | 0.06% | 8 | $578.24 |
| 69 | Vertex Pharmaceuticals Inc | VRTX | 0.05% | 1 | $540.26 |
| 70 | Ensign Group Inc/The | ENSG | 0.05% | 3 | $539.55 |
| 71 | DAVITA INC | DVA | 0.05% | 3 | $525.72 |
| 72 | Universal Health Services Inc | UHS | 0.05% | 3 | $518.61 |
| 73 | Corcept Therapeutics Inc | CORT | 0.05% | 4 | $484.20 |
| 74 | BrightSpring Health Services Inc | BTSG | 0.05% | 8 | $476.24 |
| 75 | Arrowhead Pharmaceuticals Inc | ARWR | 0.04% | 5 | $437.35 |
| 76 | Axsome Therapeutics Inc | AXSM | 0.04% | 2 | $416.06 |
| 77 | Incyte Corp | INCY | 0.04% | 3 | $381.66 |
| 78 | Summit Therapeutics Inc | SMMT | 0.04% | 29 | $360.47 |
| 79 | Exelixis Inc | EXEL | 0.03% | 6 | $322.14 |
| 80 | Royalty Pharma PLC | RPRX | 0.02% | 3 | $181.74 |
| 81 | Moderna Inc | MRNA | 0.01% | 1 | $133.32 |
| 82 | Insmed Inc | INSM | 0.01% | 1 | $125.08 |
| 83 | Viatris Inc | VTRS | 0.01% | 5 | $80.00 |
| 84 | Cytokinetics Inc | CYTK | 0.01% | 1 | $77.18 |
| 85 | BioMarin Pharmaceutical Inc | BMRN | 0.01% | 1 | $67.68 |
| 86 | 4GLD US 11/19/26 C476.95 FLX | — | -0.21% | -4 | -$2.2K |
Klik ticker untuk melihat semua ETF yang memilikinya.
Eksposur Geografis
Bobot negara sebagaimana dilaporkan oleh penyedia data. Label pasar berkembang/maju/frontier mengikuti klasifikasi yang ada di halaman Metodologi. Lindung nilai mata uang: Tidak ada indikasi hedging pada nama dana.
Distribusi
| Yield (TTM) | — | Dibayarkan (12 bulan terakhir) | — |
| Frekuensi | — | SEC yield | Tidak disediakan oleh sumber data kami — lihat halaman penerbit |
| Tanggal ex-dividen terakhir | — | Pembayaran terakhir | — |
| Pertumbuhan 1T | — | Pertumbuhan 3T / 5T (tahunan) | — / — |
Tidak ada data distribusi dalam basis data kami untuk dana ini — dana ini mungkin tidak membayar distribusi, atau riwayatnya belum dimuat.
Statistik Risiko
Likuiditas
| Volume hari ini | 111 | Volume rata-rata | 122 |
| AUM | $988.5K | Premium/Diskon | +1.35% |
| Spread bid/ask | Tidak disediakan oleh sumber data kami. Periksa layar kuotasi broker Anda; spread paling lebar pada saat pembukaan dan penutupan. | ||
Premium/discount membandingkan harga pasar tertunda dengan NAV yang terakhir dilaporkan — angka indikatif, bukan premium/discount penutupan resmi. Cara kerja likuiditas ETF →
Aliran Dana (estimasi)
| Periode | Est. arus bersih | % dari AUM awal | AUM awal → akhir |
|---|---|---|---|
| 1 Hari | $0.00 | 0.00% | $988.5K → $988.5K |
| 1 Minggu | -$4.4K | -0.44% | $988.5K → $988.5K |
Estimasi ETF Explorer: perubahan AUM yang dilaporkan dikurangi dampak pergerakan pasar, dari snapshot harian kami. Bukan data kreasi/penebusan resmi penerbit.
Sumber Daya Resmi Dana
Tautan eksternal akan membuka situs penerbit atau SEC EDGAR di tab baru. Prospektus dan dokumen resmi selalu menjadi sumber yang berwenang — tinjau sebelum berinvestasi.
Berita Terkini untuk MHIG
Tidak ada artikel yang menyebut dana ini secara langsung dalam 7 hari terakhir — menampilkan liputan ETF umum.
Panduan: AUM adalah ukuran dana. Expense ratio adalah biaya tahunan yang sudah tercermin dalam imbal hasil. NAV adalah nilai aset yang dimiliki dana per unit; harga pasar bisa sedikit di atas (premium) atau di bawah (diskon) NAV. Total return mengasumsikan distribusi diinvestasikan kembali. Setiap dataset menampilkan tanggal datanya masing-masing karena kepemilikan, aset, dan harga diperbarui pada jadwal yang berbeda.